BL Pharmtech Corp. (KOSDAQ:065170)
South Korea · Delayed Price · Currency is KRW 1,990.00
+53.00 (2.74%)
At close: Aug 24, 2026
BL Pharmtech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 55,540 | 14,620 | 20,819 | 44,929 | 55,605 | 116,549 | |
Market Cap Growth | 189.54% | -29.77% | -53.66% | -19.20% | -52.29% | -20.02% |
Enterprise Value | 52,435 | 17,550 | 25,570 | 86,785 | 100,284 | 144,445 |
Last Close Price | 1990.00 | 548.00 | 780.00 | 1683.33 | 2083.33 | 4366.67 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 11.03 | 2.25 | 2.36 | 1.83 | 2.47 | 1.38 |
PB Ratio | 5.38 | 1.84 | 0.86 | 1.41 | 1.35 | 1.78 |
P/TBV Ratio | 5.43 | 1.87 | 0.87 | 1.46 | 2.26 | 2.66 |
P/FCF Ratio | - | - | - | 5.85 | - | 46.44 |
P/OCF Ratio | - | - | - | 5.62 | - | 37.64 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 10.41 | 2.70 | 2.90 | 3.54 | 4.45 | 1.71 |
EV/FCF Ratio | - | - | - | 11.30 | - | 57.56 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.34 | 0.64 | 0.25 | 0.13 | 1.04 | 0.64 |
Debt / FCF Ratio | - | - | - | 0.56 | - | 16.69 |
Net Debt / Equity Ratio | -0.30 | -0.27 | 0.09 | -0.28 | 0.91 | 0.29 |
Net Debt / EBITDA Ratio | -67.99 | 1.43 | -0.64 | 1.43 | -9.56 | -130.44 |
Net Debt / FCF Ratio | 1.26 | 7.43 | -0.53 | -1.16 | -2.93 | 7.63 |
Asset Turnover | 0.18 | 0.24 | 0.22 | 0.33 | 0.19 | 0.64 |
Inventory Turnover | 2.51 | 2.63 | 1.64 | 1.32 | 0.87 | 6.68 |
Quick Ratio | 1.13 | 0.89 | 0.73 | 1.79 | 0.34 | 0.90 |
Current Ratio | 1.23 | 0.95 | 1.05 | 2.12 | 0.67 | 1.14 |
Return on Equity (ROE) | -91.00% | -104.28% | -20.39% | -37.90% | -27.09% | -29.05% |
Return on Assets (ROA) | -0.98% | -4.65% | -6.68% | -5.99% | -2.56% | -1.70% |
Return on Invested Capital (ROIC) | -6.77% | -12.58% | -17.60% | -14.08% | -5.88% | -3.80% |
Return on Capital Employed (ROCE) | -3.80% | -22.10% | -14.60% | -19.30% | -8.80% | -3.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -27.35% | -114.76% | -27.41% | -0.33% | -25.00% | -17.34% |
FCF Yield | -4.47% | -1.94% | -20.19% | 17.09% | -22.85% | 2.15% |
Buyback Yield / Dilution | -0.31% | -0.05% | 0.09% | 0.00% | -1.33% | -18.44% |